Hematology1 year ago
Abbott (NYSE: ABT)+ announced today that the FDA cleared its advanced Alinity h-series hematology system
FDA clearance empowers research centers to run total blood counts (CBCs) as a feature of Abbott’s Alinity group of symptomatic items. CBCs, among the most arranged...
